Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020)
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index; 1 of the 8 sources its claims cite were checked for support.
Abstract
The systemic immunity-inflammation index (SII) is a novel inflammatory marker, and aberrant blood lipid levels are linked to inflammation. This study aimed to look at the probable link between SII and hyperlipidemia. The current cross-sectional investigation was carried out among people with complete SII and hyperlipidemia data from the 2015–2020 National Health and Nutrition Examination Survey (NHANES). SII was computed by dividing the platelet count × the neutrophil count/the lymphocyte count. The National Cholesterol Education Program standards were used to define hyperlipidemia. The nonlinear association between SII and hyperlipidemia was described using fitted smoothing curves and threshold effect analyses. A total of 6117 US adults were included in our study. A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis. Age, sex, body mass index, smoking status, hypertension, and diabetes were not significantly correlated with this positive connection, according to subgroup analysis and interaction testing (p for interaction > 0.05). Additionally, we discovered a non-linear association between SII and hyperlipidemia with an inflection point of 479.15 using a two-segment linear regression model. Our findings suggest a significant association between SII levels and hyperlipidemia. More large-scale prospective studies are needed to investigate the role of SII in hyperlipidemia.
Overview
CoChat Summary
TL;DR
In a cross-sectional NHANES 2015–2020 sample of 6,117 US adults, higher systemic immunity-inflammation index (SII) was associated with higher odds of hyperlipidemia in minimally and partially adjusted models. The association was nonlinear, with an inflection point at SII 479.15, and became statistically insignificant in the fully adjusted model.
Key findings
- Among 6,117 participants, mean SII was 459.54 ± 317.28, mean age was 50.70 ± 17.43 years, 48.08% were male, and 69.72% had hyperlipidemia.
- SII/100 was positively associated with hyperlipidemia in model 1 [OR 1.04 (1.02, 1.06)] and model 2 [OR 1.03 (1.01, 1.05)], but not in fully adjusted model 3 [OR 1.02 (1.00, 1.04)].
- In SII quartile sensitivity analysis using model 2, Quartile 4 was associated with a 27.04% increased risk of hyperlipidemia versus Quartile 1 (p for trend < 0.05).
- A nonlinear association was found with an inflection point of 479.15; in women, an inverted U-shaped curve had an inflection point of 958.14. Subgroup interaction tests were not significant (p for interaction > 0.05).
Methods
- Cross-sectional study using NHANES 2015–2020 data; from 25,531 eligible people, exclusions for missing SII data (5,264), missing hyperlipidemia data (12,969), and age <20 years (1,181) yielded 6,117 participants.
- SII was calculated as platelet count × neutrophil count / lymphocyte count; hyperlipidemia was defined by NCEP ATP III criteria or reported use of cholesterol-lowering drugs.
- Multivariable logistic regression with three adjustment models, smooth curve fitting, threshold effect analysis, and subgroup/interaction testing; analyses used R and EmpowerStats with weighting.
Limitations
- The authors state that the cross-sectional design cannot establish causation and that prospective studies are needed.
- The authors state that residual confounding may remain, including long-term medication use such as steroids, which was not recorded in NHANES; they also note that the inflammation–disease interaction is complex and generalization may be improper.
- Evident from the text: the fully adjusted model 3 did not retain statistical significance, and the abstract describes “multivariate linear regression” while the Methods/Results describe multivariable logistic regression.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 21 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SII was shown to correlate significantly with hyperlipidemia in subgroups stratified by sex, BMI, and diabetes (p < 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction tests revealed that the relationship between SII and hyperlipidemia was not statistically different across strata, showing that age, sex, BMI, smoking status, hypertension, and diabetes did not significantly impact this positive correlation (p for interaction> 0.05).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, in model 3, the positive association between SII and hyperlipidemia became insignificant (1.02 (1.00, 1.04)).”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This association was significant both in model 1 (1.04 (1.02, 1.06)) and model 2 (1.03 (1.01, 1.05)).”
- Also stated in: § Abstract · plain
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 3. Results > 3.2. Association between SII and Hyperlipidemia
plainstates an associationn = 6,117 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
8 more claims
Create a free account to see all 25 claims and to verify the 7 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To minimize the influence of highly variable MHR values, MHR was scaled by multiplying by 10 (19).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“The systemic immunity-inflammation index is the dependent variable in this investigation.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.3. SII and Covariates
“SII was intended as an exposure variable in our research.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > Abstract
“A substantial positive correlation between SII and hyperlipidemia was found [1.03 (1.01, 1.05)] in a multivariate linear regression analysis.”
§ Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020) > 2. Materials and Methods > 2.4. Statistical Analysis
“To examine the association between SII and hyperlipidemia, multivariate logistic regression analysis between SII and hyperlipidemia was used”
Citations
Cites
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · cited 1×
“Adult Treatment Panel III (ATP 3) of the National Cholesterol Education Program (NCEP) classified hyperlipidemia as total cholesterol 200 mg/dL, triglycerides 150 mg/dL, HDL 40 mg/dL in males and 50 mg/dL in females, or low-density lipoprotein 130 mg/dL [21].”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · cited 1×
“In the United States, 28 million people had total cholesterol levels higher than 240 mg/dL [4].”
BackgroundHeart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · cited 1×
“In addition, hyperlipidemia significantly increases the risk of cardiovascular and immune diseases and is a significant cause of stroke and death [5].”
BackgroundTarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412 · cited 1×
“described infantile-onset STING-associated vasculopathy caused by a systemic gain-of-function mutation in the TMEM173 gene and in patients characterized by systemic inflammation [37,38].”
BackgroundSelf-citationResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“The ability of SPM to limit leukocyte infiltration and counter-regulate the production of pro-inflammatory mediators is one of its main biological functions [44].”
BackgroundInflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184 · cited 1×
“The interaction between systemic inflammation and the local immune response has been identified as the seventh cancer hallmark, and it has been shown to be involved in the initiation, development, and progression of various forms of cancer [11,12].”
Background
Cited by
Wu, C., Wu, C.-H., Lee, C., & Cheng, C. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03316-6 · Cited by 131
“htm) or a serum total cholesterol level ≥ 200 mg/dL, HDL-c < 40 mg/dl for men, HDL-c < 50 mg/dl for women, LDL-c ≥ 130 mg/dl, or triglyceride ≥ 150 mg/dl [20].”
Ma, R., Cui, L., Cai, J., Yang, N., Wang, Y., Chen, Q., Chen, W., Peng, C., Qin, H., Ding, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1323174 · Cited by 130
Liu, K., Tang, S., Liu, C., Ma, J., Cao, X., Yang, X., Zhu, Y., Chen, K., Liu, Y., Zhang, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337241 · Cited by 133
Self-citationAssociation between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome
Gao, C., Gao, S., Zhao, R., Shen, P., Zhu, X., Yang, Y., Duan, C., Wang, Y., Ni, H., Zhou, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69819-0 · Cited by 127
“Inflammation also lowers HDL cholesterol by impairing its anti-inflammatory and cholesterol transport functions 22,23 .”
BackgroundZhao, E., Cheng, Y., Yu, C., Li, H., & Fan, X. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2197652 · Cited by 80
Metadata
- Authors
- Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J.
- Affiliations
- Tianjin Medical University (CN)
- Tianjin Huanhu Hospital (CN)
- Corresponding author
- Chen, Jiageng
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-02-26
- Volume
- 15
- Issue
- 5
- Pages
- 1177
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10004774
- OpenAlex
- W4322503120
- Cited by
- 260
- References
- 52
- Citations by year
- 2026: 37 · 2025: 104 · 2024: 105 · 2023: 14
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tianjin Health Research Project (TJWJ2022QN062, 2021KJ255)
- Tianjin Municipal Education Commission (TJWJ2022QN062, 2021KJ255)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hyperlipidemia, inflammation, inflammatory markers, platelet count, neutrophil-to-lymphocyte ratio, nonlinear relationship, threshold effects, serum lipids, adults
- MeSH terms
- Adult, Cross-Sectional Studies, Humans, Hyperlipidemias, Inflammation, Nutrition Surveys, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020). https://app.cochat.ai/papers/10.3390/nu15051177
- The paper
- Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J. (2023). Association between Systemic Immunity-Inflammation Index and Hyperlipidemia: A Population-Based Study from the NHANES (2015–2020). Nutrients. https://doi.org/10.3390/nu15051177
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.